this quarterly is so vital for the share price. If cash burn is high again then I cant see it rising much. If cashburn has reduced (increased revenue, same/reduced expenditure) then we should see some positive movement. I think no one doubts the long term success of cardiocel but are gunshy into buying a share when a cap raising may come. If they cap raise for the vaccine then no one will care as we may have hit the motherload by then.
Global future, page-30
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$11.55 |
Change
-0.130(1.11%) |
Mkt cap ! $244.1M | |||
| Open | High | Low | Value | Volume |
| $11.71 | $11.89 | $11.41 | $703.3K | 60.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2 | $11.55 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $11.83 | 500 | 1 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |